Cargando…
Anti-fibrotic effect of aurocyanide, the active metabolite of auranofin
Drug repositioning has gained significant attention over the past several years. The anti-rheumatoid arthritis drug auranofin has been investigated for the treatment of other diseases, including liver fibrosis. Because auranofin is rapidly metabolized, it is necessary to identify the active metaboli...
Autores principales: | Kim, Hyun Young, Otgontenger, Undarmaa, Kim, Jun-Woo, Lee, Young Joo, Kim, Sang-Bum, Lim, Sung Chul, Kim, Young-Mi, Kang, Keon Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pharmaceutical Society of Korea
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998255/ https://www.ncbi.nlm.nih.gov/pubmed/36894745 http://dx.doi.org/10.1007/s12272-023-01438-1 |
Ejemplares similares
-
Auranofin prevents liver fibrosis by system Xc-mediated inhibition of NLRP3 inflammasome
por: Kim, Hyun Young, et al.
Publicado: (2021) -
Deleterious Alteration of Glia in the Brain of Alzheimer’s Disease
por: Kim, Eunyoung, et al.
Publicado: (2020) -
Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion
por: Kim, Hyun Young, et al.
Publicado: (2019) -
Auranofin, an Anti-rheumatic Gold Drug, Aggravates the Radiation-Induced Acute Intestinal Injury in Mice
por: Lee, Eun Sang, et al.
Publicado: (2019) -
Parthenolide-induced apoptosis of hepatic stellate cells and anti-fibrotic effects in an in vivo rat model
por: Kim, In Hee, et al.
Publicado: (2012)